STAAR Surgical Company (STAA) is Trading Higher on Unusual Volume for February 16

Equities Staff |

STAAR Surgical Company (STAA) experienced unusually high volume on Feb. 16, as the stock gained 0.32% to a closing price of $6.30. The stock saw 96,300 shares trade hands over the course of the day on 592 trades. Given that the stock’s average daily volume over the last month has been 0 shares a day, this represents a pretty substantial spike over the norm.

STAAR Surgical Company has a P/B ratio of 6.36. The stock has traded between $10.63 and $6.17 over the last 52-weeks, its 50-day SMA is now $7.07, and its 200-day SMA $8.25.

Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses.

Headquartered in Monrovia, CA, STAAR Surgical Company has 300 employees and is currently under the leadership of CEO Caren L. Mason.

For a complete fundamental analysis analysis of STAAR Surgical Company, check out’s Stock Valuation Analysis report for STAA. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Blow & Drive Interlock Corp

Blow & Drive Interlock Corp manufactures, markets, leases, installs and monitors a Breath Alcohol Ignition Interlock Device mechanism on the steering column of an automobile and into which a driver…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…